Variable | HR (CI95) | p value |
---|---|---|
Stage II | 1.657 (1.135–2.419) | 0.009a |
Stage III | 2.889 (1.954–4.274) | < 0.001a |
Stage IV | 4.205 (1.298–13.624) | 0.017a |
Age (> 59 versus < 59 years) | 1.282 (0.900–1.826) | 0.168 |
Gender (female versus male) | 0.790 (0.504–1.239) | 0.305 |
Neuroendocrine marker (positivity versus negativity) | 0.697 (0.436–1.113) | 0.131 |